Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-09-17FDA Approved: OXCARBAZEPINE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's Original Application for generic oxcarbazepine (ANDA 202961).
-
CLINICAL_TRIALS trial_result · 2012-09-11Clinical Trial Update: Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures [Phase 3]
A Phase 3 extension study reports long-term safety and efficacy of pregabalin as monotherapy for partial seizures; completed with results po…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy [Phase 2]
Phase 2 open-label study evaluating the safety of lacosamide as add-on therapy for primary generalized tonic-clonic seizures in people with …
-
FDA label_change · 2012-08-31FDA Approved: FELBAMATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for felbamate submitted by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: ECG Vector Determination
The clinical trial NCT01486056 has completed and reports on determining ECG vector for the vagus nerve stimulation system in epilepsy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Physiological and Biomechanical Data Collection Study in Epilepsy Subjects
The clinical trial in epilepsy subjects completed data collection for a physiological and biomechanical study sponsored by Cyberonics.
-
EMA withdrawal · 2012-08-16EMA Lapsed: Exalief (eslicarbazepine acetate) — BIAL - Portela Ca, S.A.
EMA status indicates Exalief (eslicarbazepine acetate) has lapsed in Europe.
-
CLINICAL_TRIALS safety_alert · 2012-08-06Clinical Trial Update: WEUSKOP6166: Lamotrigine and Aseptic Meningitis
Clinical trial WEUSKOP6166 studying lamotrigine in epilepsy has an update related to aseptic meningitis risk. The safety signal centers on a…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy [Phase 2]
Phase 2 trial evaluating the safety and efficacy of 333369 for partial epilepsy has completed.
-
FDA approval · 2012-08-01FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Lamictal (lamotrigine) from GlaxoSmithKline LLC. This action may involve labeling or indication …
-
FDA approval · 2012-08-01FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for LAMICTAL ODT (lamotrigine) by GlaxoSmithKline LLC, updating the labeling for the oral disintegra…
-
FDA approval · 2012-08-01FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for LAMICTAL XR (lamotrigine) submitted by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Low and High Dose Zonisamide in Children as Monotherapy [Phase 4]
Phase 4 clinical trial evaluating low- and high-dose zonisamide as monotherapy in children with epilepsy. Results have been posted.
-
CLINICAL_TRIALS research · 2012-07-26Clinical Trial Update: Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation [Phase 4]
A Phase 4 comparative trial evaluating zonisamide versus carbamazepine as initial monotherapy for epilepsy, focusing on efficacy and safety.
-
FDA approval · 2012-07-20FDA Approved: LEVETIRACETAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approves a supplemental application for Levetiracetam from Lupin Pharmaceuticals, indicating an approved update to labeling or indic…
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Low Glycemic Index Diet Therapy in Children With Refractory Epilepsy [Phase 3]
A Phase 3 clinical trial is evaluating a low glycemic index diet therapy in children with refractory epilepsy. The current trial status is u…
-
FDA approval · 2012-07-19FDA Approved: LEVETIRACETAM SOLUTION — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application to add a liquid levetiracetam formulation (LEVETIRACETAM SOLUTION) from Chartwell RX, LLC. The appro…
-
FDA label_change · 2012-07-19FDA Approved: CLONAZEPAM — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for Accord Healthcare's clonazepam (generic clonazepam), resulting in updated labeling for the p…
-
FDA approval · 2012-07-19FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for EPITOL (carbamazepine) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2012-07-19FDA Approved: LEVETIRACETAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for a generic Levetiracetam product. This notice indicates a supplemental a…
-
CLINICAL_TRIALS research · 2012-07-19Clinical Trial Update: Adverse Event Scale in Patients With Epilepsy (aEscape) - A European Survey for Physicians With Epilepsy Patients
A European physician survey (aEscape) evaluated an adverse event scale used in epilepsy patients. The study was sponsored by UCB Pharma and …
-
FDA approval · 2012-06-25FDA Approved: PRIMIDONE — Supplemental Application (Oxford Pharmaceuticals, LLC)
The FDA approved a supplemental application for Primidone submitted by Oxford Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of RWJ-333369 as add-on therapy for partial-onset seizures; the study has complete…
-
FDA approval · 2012-06-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for carbamazepine from Torrent Pharmaceuticals Limited. This represents a supplemental approval …
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures [Phase 3]
This open-label Phase 3 trial evaluated levetiracetam in Japanese pediatric patients with partial seizures. Results were posted in 2012 afte…